Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
411.4 USD | +0.91% | -0.75% | +1.10% |
Chart calendar Vertex Pharmaceuticals Incorporated
Upcoming events on Vertex Pharmaceuticals Incorporated
Past events on Vertex Pharmaceuticals Incorporated
2024-03-11 04:00 pm | Leerink Partners Global Biopharma Conference |
2024-03-05 10:30 am | TD Cowen Health Care Conference |
2024-02-05 04:30 pm | Q4 2023 Earnings Call |
2024-02-05 04:01 pm | Q4 2023 Earnings Release |
2024-01-30 08:00 am | VX-548 Phase 3 Study Results Call |
2024-01-08 11:15 am | JPMorgan Healthcare Conference |
2023-12-13 08:00 am | VX-548 Phase 2 Study Results Call |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No:4997 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No:4999 |
2023-12-11 08:00 pm | American Society of Hematology Meeting - Abstract Number #1053 |
2023-12-11 07:45 pm | American Society of Hematology Meeting - Abstract Number #1052 |
2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No:3900 |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No:3678 |
2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No:3674 |
2023-11-14 03:30 am | Jefferies London Healthcare Conference - Fireside Chat |
2023-11-09 12:00 pm | UBS BioPharma Conference - Fireside Chat |
2023-11-06 04:30 pm | Q3 2023 Earnings Call |
2023-11-06 04:01 pm | Q3 2023 Earnings Release |
2023-09-13 11:30 am | Morgan Stanley Global Healthcare Conference |
2023-08-01 04:30 pm | Q2 2023 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 163 3 759 10.74% | 6 206 6 159 0.76% | 7 574 7 502 0.97% | 8 931 8 933 -0.03% | 9 869 9 861 0.08% | 10 731 |
EBITDA Million USD | Released Forecast Spread | 1 893 1 770 6.92% | 3 601 3 649 -1.33% | 4 470 4 490 -0.46% | 4 941 5 101 -3.12% | 4 556 4 734 -3.75% | 5 315 |
EBIT Million USD | Released Forecast Spread | 1 786 1 609 11.02% | 3 491 3 471 0.58% | 4 344 4 345 -0.02% | 4 793 4 832 -0.81% | 4 375 4 461 -1.94% | 4 967 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 395 964 44.64% | 3 117 2 891 7.82% | 2 730 2 761 -1.12% | 4 232 4 155 1.86% | 4 380 4 415 -0.8% | 4 898 |
Net income Million USD | Released Forecast Spread | 1 177 796 47.91% | 2 712 2 608 3.99% | 2 342 2 295 2.07% | 3 322 3 287 1.06% | 3 620 3 574 1.28% | 3 895 |
EPS USD | Released Forecast Spread | 4,51 3,08 46.48% | 10,3 9,87 4.24% | 9,01 8,80 2.4% | 12,8 12,8 0.17% | 13,9 13,7 1.52% | 15,0 |
Announcement Date | 30/01/20 | 01/02/21 | 26/01/22 | 07/02/23 | 05/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 073 2 007 3.29% | 2 098 2 074 1.14% | 2 196 2 132 3.03% | 2 334 2 227 4.82% | 2 303 2 303 -0.01% | 2 375 2 336 1.67% | 2 493 2 421 3% | 2 484 2 502 -0.73% | 2 518 2 515 0.12% | 2 573 | 2 655 | 2 710 | 2 790 | 2 690 |
EBITDA Million USD | Released Forecast Spread | 1 215 1 255 -3.17% | 1 210 1 285 -5.81% | 1 256 | 1 277 | 1 285 | 1 250 | ||||||||
EBIT Million USD | Released Forecast Spread | 1 124 1 126 -0.15% | 1 167 1 188 -1.82% | 1 187 1 179 0.67% | 1 289 1 210 6.55% | 1 150 1 197 -3.94% | 902 971 -7.11% | 1 148 1 246 -7.89% | 1 173 1 239 -5.32% | 1 151 1 237 -6.9% | 1 191 | 1 221 | 1 240 | 1 298 | 1 333 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 871 908 -4.05% | 955 995 -3.99% | 1 024 994 3.05% | 1 176 1 038 13.29% | 1 077 990 8.81% | 892 850 4.85% | 1 162 1 132 2.56% | 1 179 1 136 3.76% | 1 148 1 199 -4.3% | 1 184 | 1 219 | 1 248 | 1 280 | 1 381 |
Net income Million USD | Released Forecast Spread | 770 720 7% | 762 801 -4.8% | 811 799 1.47% | 931 820 13.42% | 819 779 5.08% | 700 677 3.43% | 916 895 2.29% | 1 035 909 13.87% | 969 952 1.74% | 946 | 971 | 989 | 1 003 | 1 091 |
EPS USD | Released Forecast Spread | 3,00 2,76 8.61% | 2,96 3,14 -5.62% | 3,13 3,07 1.98% | 3,59 3,27 9.92% | 3,15 3,09 1.86% | 2,69 2,67 0.78% | 3,52 3,43 2.58% | 3,97 3,48 14.23% | 3,71 3,57 4.04% | 3,69 | 3,76 | 3,82 | 3,92 | 4,12 |
Announcement Date | 26/01/22 | 05/05/22 | 04/08/22 | 27/10/22 | 07/02/23 | 01/05/23 | 01/08/23 | 06/11/23 | 05/02/24 | - | - | - | - | - |
Past sector events for Vertex Pharmaceuticals Incorporated
2024-03-18 04:15 pm | ALPINE IMMUNE SCIENCES, INC.: Q4 2023 Earnings Release |
2024-03-17 | WUXI APPTEC CO., LTD.: Q4 2023 Earnings Release |
2024-03-17 | AKESO, INC.: Q4 2023 Earnings Release |
2024-03-14 04:05 pm | LARIMAR THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-14 04:05 pm | ALLOGENE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-14 07:00 am | AUTOLUS THERAPEUTICS PLC: Q4 2023 Earnings Release |
2024-03-13 | CABALETTA BIO, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-12 04:01 pm | LONGBOARD PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
2024-03-11 04:15 pm | ANAPTYSBIO, INC.: Q4 2023 Earnings Release |
2024-03-11 04:05 pm | ORIC PHARMACEUTICALS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Vertex Pharmaceuticals Incorporated - Nasdaq
- Calendar Vertex Pharmaceuticals Incorporated